IIR's Partnerships with CROs

Apr. 28, 2009-Apr. 30, 2009
Rosen Shingle Creek Hotel
Orlando, FL
www.iirusa.com/cropartners/welcome-to-CROs.xml

Description:

Adapting to Constant Change: How Partners are Working Together Through the Organization Stages

Gary Tyson, Senior Vice President and Practice Area Lead of the Clinical Development Practice, moderates a panel on managing change with clinical partner organizations.

Abstract:

Adapting to Constant Change: How Partners are Working Through the
Organizational Stages
 
Moderator:
Gary Tyson, Senior Vice President, Clinical Development Practice, Campbell Alliance
 
Speakers:
Anthony Carita, Director, Clinical Outsourcing, Otsuka Pharmaceutical Development & Commercialization
Jane Fayer, Associate Director, Outsourcing Management, Novartis Pharmaceuticals,
Nagaraja Srivatsan, Senior Vice President of Client Solutions, Cognizant
Ramita Tandon, Director of Project Management, Paraxel International
 
Changes are more dramatic than ever before in today’s pharmaceutical industry with layoffs impacting resources and mergers effecting increased competition and long periods of inactivity. The trickle down delay to CROs is frightening. From a business development perspective dealing with change management as the industry deals with ever increasing pressures on trial design, timelines and budgets can be frustrating and costly when a study is delayed or cancelled, or when new management comes in changing strategy and objectives.  As sponsors increasingly share more responsibility with CRO partners and have less time/resources for oversight, how are companies dealing with the changes that ensue?
 
  • Changing doers into managers - How providers need to change to respond to this
  • Risk tolerance providers must bear in an uncertain environment
  • IP, manpower, time management
  • Dealing with sometimes inexperienced or difficult teams on both sides

View Entire Event Calendar

Don't Miss